Liothyronine Sodium
NDC 43063-884, Liothyronine Sodium, tablet, from PD-Rx Pharmaceuticals, Inc..
- Product NDC
- 43063-884
- Status
- Listed
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA200295
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/43063-884 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LIOTHYRONINE SODIUM25 ug/1
Pharmacologic classes
Triiodothyronine [CS]; l-Triiodothyronine [EPC]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 43063-884-30 | 43063088430 | 30 TABLET in 1 BOTTLE, PLASTIC (43063-884-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/76fa4eb6-fefa-4e97-9543-f81e465743e6
Use it
Look up 43063-884 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/43063-884 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 43063-884. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.